US Patent 11879004 Modified binding polypeptides for optimized drug conjugation
Patent 11879004 was granted and assigned to Genzyme on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+299 characters)
US Patent 11879004 Modified binding polypeptides for optimized drug conjugation
Article
Patent abstract
Engineered antibodies that are stable and can be conjugated to a ligand or drug at a ligand/drug to antibody ratio of above 3, making these conjugates suitable for treatment of a variety of indications, are provided. Methods of producing these engineered antibodies are also provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Francis Duffieux0
Huawei Qiu0
Marie-Priscille Brun0
Qun Zhou0
Sunghae Park0
Date of Patent
January 23, 2024
0Patent Application Number
171870390
Date Filed
February 26, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11879004 Modified binding polypeptides for optimized drug conjugation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.